Over-the-counter (OTC) drugs also called as non-prescription drugs are medicines that do not require prescription from healthcare professionals for selling it to consumers. Consumer can follow the instruction mentioned on label and these drugs are safe to use. These drugs are available at pharmacies, supermarkets, general stores, and gas stations across several countries. Click To Read More On Over-the-counter Drugs Market
Increasing prevalence of digestion disorders, common flu, and cold is driving growth of the market
According to American Nutrition Association, 2016, around 70 million people suffer from some form of digestion disorder such as indigestion, acid reflux, irritable bowel syndrome, and constipation daily. Patients suffering from these conditions are reported to use non-prescription medicines. OTC drugs widely used to treat symptoms of cold and flu worldwide. Increasing prevalence of viral infections causing cold and flu is creating a favorable environment for growth of OTC drugs market.
North America to hold the leading position in the global over-the-counter drugs market, owing to well established healthcare structure
On the basis of geography, the global over-the-counter drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global over-the-counter drugs market, followed by Europe, owing to growing patient awareness regarding consumption of OTC drugs, leading to self-medication practices. According to Consumer Healthcare Protection Act 2015, an estimated 81% adults in the U.S. use OTC medicines as their first response to minor ailments. Moreover, the same data states that U.S. had an around 54,000 pharmacies in 2015 and over 750,000 retail outlets selling OTC drugs.
Ask For Sample Copy Of This Report : https://www.coherentmarketinsights.com/insight/request-sample/1218
Increasing awareness regarding self-medication to boost OTC drugs market growth
Increasing inclination of the populace towards self-medication for treatment of minor health conditions, low pricing of these drugs, convenience of direct purchase, as well as innovations and developments in the dosage forms of these drugs is fueling growth of the market.
Key players are focusing into strategic alliances and partnerships with companies in distant geographies to increase visibility of product. For instance, in January 2018, Nuvo Pharmaceuticals, Inc. acquired ex-U.S. product and existing royalty streams for ‘Resultz’, an OTC treatment for head lice from Piedmont Pharmaceuticals LLC. Key players operating in the global over-the-counter drugs market include Alkem Laboratories Limited, GlaxoSmithKline Plc., Boehringer Ingelheim GmbH, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Johnson and Johnson Inc., Pfizer, Inc., Novartis AG, Merck KGaA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.